U.S. CoC challenges EMA on data transparency
By Nuala Moran
Tuesday, June 10, 2014
As the EMA management board faces up to a crunch meeting on Thursday this week at which it is due to finally decide its clinical trials data transparency rules, the U.S. Chamber of Commerce (CoC) has challenged its approach in a critical report that said the proposed policy calls into question the agency's attitudes to the "inherent confidentiality" of data submitted in marketing applications and its role as a custodian of the information.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.